Frederiksberg, Denmark

Per Vedso

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 379(Granted Patents)


Location History:

  • Frederiksberg, DK (2006 - 2011)
  • Vaerlose, DK (2005 - 2013)
  • Vaerloese, DK (2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Per Vedso: Pioneering Innovator in Therapeutic Agents

Introduction:

Per Vedso, a distinguished inventor hailing from Frederiksberg, DK, has made significant contributions to the field of biopharmaceuticals and therapeutic agents. With a portfolio of 14 patents to his name, Vedso's groundbreaking work has revolutionized the treatment of various diseases, particularly in the management of type 2 diabetes.

Latest Patents:

Among his latest patents is the development of aryl carbonyl derivatives as therapeutic agents. These compounds serve as activators of glucokinase, offering novel approaches to managing diseases where enhancing glucokinase activity is crucial. Additionally, Vedso's invention of urea glucokinase activators showcases his commitment to advancing the field of medicine through innovative drug formulations.

Career Highlights:

Having worked in renowned companies like Novo Nordisk A/S and Nero Nordisk A/S, Per Vedso has honed his expertise in pharmaceutical research and development. His contributions have not only enriched the intellectual property landscape but have also laid the foundation for groundbreaking advancements in the healthcare industry.

Collaborations:

Throughout his career, Per Vedso has collaborated with esteemed professionals such as Jesper F Lau and Anthony Murray. These partnerships have fostered a culture of innovation, allowing for the exchange of ideas and the realization of pioneering research projects that push the boundaries of medical science.

Conclusion:

In conclusion, Per Vedso stands as a beacon of innovation, inspiring the next generation of inventors to think boldly and create solutions that shape the future of technology. His dedication to developing novel therapeutic agents underscores his commitment to improving global health outcomes and cementing his legacy as a visionary in the field of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…